Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia

Medical Oncology

Volumn 29, Issue 4, 2012, Pages 2323-2331

  Zhu, Yuan Dong ^a,b   Wang, Li ^a   Sun, Chao ^a,c   Fan, Lei ^a   Zhu, Dan Xia ^a   Fang, Cheng ^a   Wang, Yin Hua ^a   Zou, Zhi Jian ^a   Zhang, Su Jiang ^a   Li, Jian Yong ^a   Xu, Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b The First Hospital of Changzhou   (China)

^c WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Acute leukemia; FLT3 ITD mutation; Karyotype; miRNA; qRT PCR

Indexed keywords

FLT3 LIGAND; LET 7B; MICRORNA; MICRORNA 128; MICRORNA 155; MICRORNA 181 A; MICRORNA 223; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROPHORESIS; FEMALE; HUMAN; INFANT; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; FEMALE; FMS-LIKE TYROSINE KINASE 3; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KARYOTYPE; LEUKEMIA; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROGNOSIS;

EID: 84868004595     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0140-5     Document Type: Article

References (34)

1. Slezak-Prochazka I, Durmus S, Kroesen BJ, et al. MicroRNAs, macrocontrol: regulation of miRNA processing. RNA. 2010;16(6):1087-95.
2. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92-105.
3. Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11(9):644-56.
4. Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007;297:1901-8.
5. Munker R, Calin GA. MicroRNA profiling in cancer. Clin Sci (Lond). 2011;121(4):141-158.
6. Bissels U, Bosio A, Wagner W. MicroRNAs are shaping the hematopoietic landscape. Haematologica. 2011 [Epub ahead of print].
7. Paolini S, Gazzola A, Sabattini E, et al. Pathobiology of acute lymphoblastic leukemia. Semin Diagn Pathol. 2011;28(2):124-34.
8. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030-43.
9. Hong WJ, Medeiros BC. Unfavorable-risk cytogenetics in acute myeloid leukemia. Hematol Expert Rev. 2011;4(2):173-184.
10. De Jonge HJ, Huls G, De Bont ES. Gene expression profiling in acute myeloid leukemia. Neth J Med. 2011;69(4):167-76.
11. Wieser R, Scheideler M, Hackl H, et al. microRNAs in acute myeloid leukemia: expression patterns, correlations with genetic and clinical parameters, and prognostic significance. Genes Chromosomes Cancer. 2010;49(3):193-203.
12. Ferrara F, Palmieri S, Leoni F. Clinically useful prognostic factors in acute myeloid leukemia. Crit Rev Oncol Hematol. 2008;66(3):181-93.
13. Odenike O, Thirman MJ, Artz AS, et al. Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet? Semin Oncol. 2011;38(2):196-214.
14. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.
15. Zhu DX, Miao KR, Fang C, Zhu W, Fan L, Zhu HY, Zhuang Y, Hong M, Liu P, Xu W, Li JY. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia. Leuk Res. 2011;35(6):730-4.
16. Shaffer LG, Tommerup N, editors. ISCN 2005: an international system for human cytogenetic nomenclature. Basel: S. Karger; 2005.
17. Xu W, Zhou HF, Fan L, Qian SX, Chen LJ, Qiu HR, Zhang SJ, Li JY. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16. Onkologie. 2008;31(8-9):440-4.
18. Qiao C, Zhang SJ, Chen LJ, Miao KR, Zhang JF, Wu YJ, Qiu HR, Li JY. Identification of the STAT5B-RARα fusion transcript in an acute promyelocytic leukemia patient without FLT3, NPM1, c-Kit and C/EBPα mutation. Eur J Haematol. 2011;86(5):442-6.
19. Debernardi S, Skoulakis S, Molloy G, et al. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia. 2007;21(5):912-6.
20. Mi S, Lu J, Sun M, et al. MiRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA. 2007;104(50):19971-6.
21. Georgantas RW 3rd, Hildreth R, Morisot S, et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA. 2007;104(8):2750-5.
22. Fazi F, Racanicchi S, Zardo G, et al. Epigenetic silencing of the myelopoiesis regulator miRNA-223 by the AML1/ETO oncoprotein. Cancer Cell. 2007;12:457-66.
23. Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451(7182):1125-9.
24. Myatt SS, Wang J, Monteiro LJ, et al. Definition of miRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res. 2010;70(1):367-77.
25. Shell S, Park SM, Radjabi AR, et al. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A. 2007;104:11400- 11405.47.
26. Lee YS, Dutta A. The tumor suppressor miRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21:1025-1103.
27. Larson RA. Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia. Chem Biol Interact. 2010;184(1-2):21-5.
28. Marcucci G, Radmacher MD, Mrózek K, et al. MicroRNA expression in acute myeloid leukemia. Curr Hematol Malig Rep. 2009;4(2):83-8.
29. Stone RM. Prognostic factors in AML in relation to (ab)normal karyotype. Best Pract Res Clin Haematol. 2009;22(4):523-8.
30. Tili E, Croce CM, Michaille JJ. miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol. 2009;28(5):264-84.
31. O'Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med. 2008;205(3):585-94.
32. Garzon R, Volinia S, Liu C, et al. MiRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008;111:3183-9.
33. Iguchi H, Ochiya T. Application of microRNAs to cancer therapy. Gan To Kagaku Ryoho. 2010;37(3):389-95.
34. Ortiz-Quintero B. RNA interference: from origins to a novel tool for gene silencing. Rev Invest Clin. 2009;61(5):412-27.